Hydrogen Sulfide

Hydrogen Sulfide

SCHEMBL532933

[15SH2]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8021784 1.00
SCHEMBL8039678 1.00
SCHEMBL29449401 1.00
SCHEMBL8465583 1.00
SCHEMBL107071 1.00
SCHEMBL21806294 1.00
SCHEMBL11358424 1.00
SCHEMBL1226 1.00
SCHEMBL11347905 1.00
SCHEMBL28130404 1.00

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-2281253-Y Multifunctional apparatus for carpenter plane and metal shaper ZHANG RUILONG (CN) 1998-05-13 CN claimed
EP-4360340-A1 UE FLIGHT PATH REPORTING QUALCOMM INCORPORATED (US) 2024-05-01 EP disclosed
EP-4221572-A1 INTERACTIVE 2D SCATTER PLOT OF EGM CHARACTERISTIC METRICS Boston Scientific Scimed Inc. (US) 2023-08-09 EP disclosed
WO-2022271281-A1 UE FLIGHT PATH REPORTING QUALCOMM INCORPORATED (US) 2022-12-29 WO disclosed
EP-3931331-A1 AAV VECTOR-MEDIATED DELETION OF LARGE MUTATIONAL HOTSPOT FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY Duke University (US) 2022-01-05 EP disclosed
EP-3923743-A1 RECONSTITUTED COCOA MATERIAL FOR GENERATING AEROSOLS Schweitzer-Mauduit International, Inc. (US) 2021-12-22 EP disclosed
WO-2020214609-A1 AAV VECTOR-MEDIATED DELETION OF LARGE MUTATIONAL HOTSPOT FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY DUKE UNIVERSITY (US) 2020-10-22 WO disclosed
EP-3721233-A2 METHODS FOR AIDING IN THE DIAGNOSIS AND EVALUATION OF A SUBJECT WHO HAS SUSTAINED AN ORTHOPEDIC INJURY AND THAT HAS OR MAY HAVE SUSTAINED AN INJURY TO THE HEAD, SUCH AS MILD TRAUMATIC BRAIN INJURY (TBI), USING GLIAL FIBRILLARY ACIDIC PROTEIN (GFAP) AND/OR UBIQUITIN CARBOXY-TERMINAL HYDROLASE L1 (UCH-L1) Abbott Laboratories (US) 2020-10-14 EP disclosed
WO-2020167803-A1 RECONSTITUTED COCOA MATERIAL FOR GENERATING AEROSOLS SCHWEITZER-MAUDUIT INTERNATIONAL, INC. (US) 2020-08-20 WO disclosed
EP-3635119-A2 COMPOSITIONS AND METHODS FOR GENOME EDITING Vilmorin & Cie (FR) 2020-04-15 EP disclosed
WO-2009042801-A2 INTEGRATION OF AN INTERNET-SERVING DATACENTER WITH A THERMAL POWER STATION AND REDUCING OPERATING COSTS AND EMISSIONS OF CARBON DIOXIDE CICHANOWICZ J EDWARD (US) 2009-04-02 WO disclosed
WO-2009014850-A2 DISPENSING NOZZLE ASSEMBLY THE COCA-COLA COMPANY (US) 2009-01-29 WO disclosed
EP-2001358-A2 GLYCOPROTEIN SYNTHESIS AND REMODELING BY ENZYMATIC TRANSGLYCOSYLATION University Of Maryland Biotechnology Institute (US) 2008-12-17 EP disclosed
WO-2008137805-A1 5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS AMIRA PHARMACEUTICALS, INC. (US) 2008-11-13 WO disclosed
EP-1973575-A2 BIOCOMPATIBLE FLUORESCENT METAL OXIDE NANOPARTICLES Visen Medical, Inc. (US) 2008-10-01 EP disclosed
WO-2008036299-A2 EDIBLE WATER-SOLUBLE FILM CONTAINING A FOAM REDUCING FLAVORING AGENT MONOSOL RX LLC (US) 2008-03-27 WO disclosed
WO-2007136413-A2 BIOCOMPATIBLE FLUORESCENT METAL OXIDE NANOPARTICLES VISEN MEDICAL, INC. (US) 2007-11-29 WO disclosed
WO-2007133855-A2 GLYCOPROTEIN SYNTHESIS AND REMODELING BY ENZYMATIC TRANSGLYCOSYLATION UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE (US) 2007-11-22 WO disclosed
CN-2281253-Y Multifunctional apparatus for carpenter plane and metal shaper ZHANG RUILONG (CN) 1998-05-13 CN disclosed
CN-1130557-A Woodworking anti-cancer multipurpose machine for planing four boards and bidirectional coarse or fine planing metal ZHANG RUILONG (CN) 1996-09-11 CN disclosed